{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:01:00Z","timestamp":1791979260771,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.psychres.2018.05.075","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T11:11:23Z","timestamp":1527765083000},"page":"85-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Prescription opioid use among individuals with serious mental illness"],"prefix":"10.1016","volume":"267","author":[{"given":"Stanislav","family":"Spivak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amethyst","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Mojtabai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2018.05.075_bib0001","series-title":"Injury Prevention & Control: Prescription Drug Overdose","year":"2015"},{"key":"10.1016\/j.psychres.2018.05.075_bib0002","first-page":"1","article-title":"Drug-poisoning deaths involving opiate analgesics: United States, 1999\u20132011","volume":"166","author":"Chen","year":"2014","journal-title":"NCHS Data Brief"},{"issue":"5","key":"10.1016\/j.psychres.2018.05.075_bib0003","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/0020764017712302","article-title":"Social Network, recovery attitudes, and internal stigma among those with serious mental illness","volume":"63","author":"Cullen","year":"2017","journal-title":"Inte. J. Soc. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2018.05.075_bib0004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.psychres.2018.05.075_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AJP.0b013e3181b99f35","article-title":"Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance abuse disorders: the TROUP study","volume":"26","author":"Edlund","year":"2010","journal-title":"Clin. J. Pain"},{"issue":"1\u20132","key":"10.1016\/j.psychres.2018.05.075_bib0006","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2010.05.017","article-title":"Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study","volume":"112","author":"Edlund","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.psychres.2018.05.075_bib0007","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00005650-200412000-00010","article-title":"The revised behavior and symptom: identification scale (BASIS-R): reliability and validity","volume":"42","author":"Eisen","year":"2004","journal-title":"Med. Care"},{"issue":"4","key":"10.1016\/j.psychres.2018.05.075_bib0008","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1041-2972.2005.0020.x","article-title":"Polypharmacy in the elderly: a literature review","volume":"17","author":"Fulton","year":"2005","journal-title":"J. Am. Acad. Nurse Pract."},{"key":"10.1016\/j.psychres.2018.05.075_bib0009","unstructured":"FDA 2016. FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use. FDA news release."},{"issue":"2","key":"10.1016\/j.psychres.2018.05.075_bib0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/jurban\/jtg026","article-title":"Intentional overdose among heroin overdose survivors","volume":"80","author":"Heale","year":"2003","journal-title":"J. Urban Health"},{"issue":"2","key":"10.1016\/j.psychres.2018.05.075_bib0011","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.psychres.2018.05.075_bib0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/15504263.2013.867199","article-title":"Opiate dependence in schizophrenia: case presentation and literature review","volume":"10","author":"Kern","year":"2014","journal-title":"J. Dual Diagn."},{"issue":"2009","key":"10.1016\/j.psychres.2018.05.075_bib0013","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2009.01.019","article-title":"Pathways between nonmedical opioid use\/dependence and psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions","volume":"103","author":"Martins","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.psychres.2018.05.075_bib0014","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/pds.4278","article-title":"National trends in long-term use of presription opioids","volume":"27","author":"Mojtabai","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"3","key":"10.1016\/j.psychres.2018.05.075_bib0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/JCP.0000000000000311","article-title":"Interrater reliability of the modified monitoring of side effects scale for assessment of adverse events of psychiatric medication in clinical and research setting","volume":"35","author":"Nugent","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2018.05.075_bib0016","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jsr.2012.08.009","article-title":"Prescription drug overdoses: a review","volume":"43","author":"Paulozzi","year":"2012","journal-title":"J. Saf. Res."},{"issue":"2","key":"10.1016\/j.psychres.2018.05.075_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/02791072.2017.1295334","article-title":"Medicalizing the opioid epidemic in the U.S. in the era of healthcare reform","volume":"49","author":"Smith","year":"2017","journal-title":"J. Psychoact. Drugs"},{"issue":"19","key":"10.1016\/j.psychres.2018.05.075_bib0018","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1001\/archinte.166.19.2087","article-title":"Association between mental health disorders, problem drug use, and regular prescription opioid use","volume":"166","author":"Sullivan","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.psychres.2018.05.075_bib0019","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117321224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178117321224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T21:15:47Z","timestamp":1560201347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178117321224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":19,"alternative-id":["S0165178117321224"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2018.05.075","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription opioid use among individuals with serious mental illness","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2018.05.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}